A01=David S. Zuckerman
advanced metrics for R&D improvement
Author_David S. Zuckerman
Balanced Scorecard Metrics
case study methodology
Category=KC
Category=KJC
Category=KND
Cost Performance Index
CRF Page
CRO
Cycle Time
database
drug development process
eq_bestseller
eq_business-finance-law
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
FAA
Federal Aviation Administration
Future State Vision
growth
High Throughput Screening
Improve Cycle Times
Internal Performance Metrics
lock
map
Metrics System
metrics systems
NOAC
organisational effectiveness measurement
organizational
organizational growth metrics
Organizational Growth Strategies
Performance Improvement Systems
Performance Metrics
pharmaceutical innovation management
rejection
Rejection Tags
research performance evaluation
Run Chart
Schedule Performance Index
scientific productivity analysis
Shared Resource Department
Simple Run Chart
Site Selection
Sled Dog Racing
Spider Diagram
strategies
strategy
Strategy Map
strategy-driven metrics system
system
tags
Zuckerman's pharmaceutical metrics
Product details
- ISBN 9781138254763
- Weight: 270g
- Dimensions: 210 x 297mm
- Publication Date: 06 Mar 2017
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Paperback
Secure
checkout
Fast Shipping
Easy returns
'What gets measured gets fixed' and this is as true of the pharmaceutical industry as any other. The problem is that pharmaceutical businesses are complex. Drug research and development involves extended and expensive processes; defining appropriate metrics for these processes is not easy, yet ineffective or misguided metrics can be more damaging than none at all. David Zuckerman's Pharmaceutical Metrics is an extremely practical guide to selecting a system, selling it to top management, choosing and defining the right metrics for your system, communicating and displaying the results. And because metrics are about how to shape and develop your business, he explores how to deploy them organization-wide and make sure that they are driving business improvement. In order to reflect the needs of different types of pharmaceutical company the author uses four sample companies, throughout the book, to illustrate the principles for 'big pharma', 'micro pharma', a virtual development company and a CRO. This highly practical book provides a step-by-step guide to creating a state-of-the-art, strategy-driven metrics system for pharmaceutical R&D, supported by case studies of the techniques applied and tips for optimizing the system.
David S. Zuckerman is the world's foremost expert in the area of pharmaceutical R &D metrics, and lectures internationally on pharmaceutical metrics and balanced scorecards. He is owner and principal of Customized Improvement Strategies LLC - a management consulting firm that focuses on process improvement, organizational development, leadership development and change management; with clients that include large and small pharma R& D organizations, CROs and academic medical centers. Find out more about his work at www.rx-business.com
